XML 23 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations and Comprehensive Loss
£ in Millions
 12 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
Mar. 31, 2021
USD ($)
$ / shares
Mar. 31, 2020
USD ($)
$ / shares
Operating expenses:      
Research and development $ (1,301,178) $ (173,821) $ (518,098)
Operating Expenses (4,916,388) (3,192,385) (1,016,548)
Total operating expenses (6,217,566) (3,366,206) (1,534,646)
Finance Income 48,125
Finance (expense) (1,123) (1,158)
Impairment of loan (11,172) (132,668)
Loss from operations before income taxes (6,217,566) (3,378,501) (1,620,347)
Income tax provision 786,521 24,994 76,288
Loss for the year (5,431,045) (3,353,507) (1,544,059)
Other Comprehensive loss:      
Exchange differences on translating foreign operations (837,152) 346,365 86,654
Comprehensive loss $ (6,268,197) $ (3,007,142) $ (1,457,405)
Basic and diluted loss per share attributable to common shareholders | $ / shares $ (0.01) $ (0.01) $ (0.00)